-H2ax Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results From 2 Phase I Clinical Trials of SJG-136 (SG2000)

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-2529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

MicroRNA-138 Modulates DNA Damage Response by Repressing Histone H2AX Expression

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2011English

Inhibition of the Nedd8 System Sensitizes Cells to DNA Interstrand Cross-Linking Agents

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2012English

Telomeric DNA Damage by Topoisomerase I

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

DNA Damage-Processing Pathways Involved in the Eukaryotic Cellular Response to Anticancer DNA Cross-Linking Drugs

Molecular Pharmacology
Molecular MedicinePharmacology
2004English

Characterization of DNA Repair Foci in Root Cells of Arabidopsis in Response to DNA Damage

Frontiers in Plant Science
Plant Science
2019English

Linking DNA Damage, NAD+/SIRT1, and Aging

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2014English

ZNF506-dependent Positive Feedback Loop Regulates H2AX Signaling After DNA Damage

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Early Models of DNA Damage Formation

Journal of Physics: Conference Series
AstronomyPhysics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy